We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
+$546M
(+11%)
Cap. Flow
+$263M
Cap. Flow
% of AUM
4.63%
Top 10 Holdings %
Top 10 Hldgs %
11.85%
Holding
1,134
New
196
Increased
491
Reduced
251
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$35.7M |
| 2 |
Merck
MRK
|
+$30.3M |
| 3 |
Microsoft
MSFT
|
+$22.4M |
| 4 |
Yum China
YUMC
|
+$17.6M |
| 5 |
Occidental Petroleum
OXY
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$36.5M |
| 2 |
Intel
INTC
|
+$32.4M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$17.1M |
| 4 |
NVR
NVR
|
+$16.3M |
| 5 |
Deere & Co
DE
|
+$16.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Financials | 17.92% |
| 3 | Industrials | 13.48% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Healthcare | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XL
51
DELISTED
XL Group Ltd.
XL
| $25.4M | 0.45% |
723,126
+26,800
| +4% | +$1.04M |
|
|
ZNGA
52
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $25.3M | 0.44% |
6,322,676
-58,700
| -0.9% | -$229K |
|
|
DNB
53
DELISTED
Dun & Bradstreet
DNB
| $25M | 0.44% |
210,856
+55,937
| +36% | +$6.64M |
|
54
Archer Daniels Midland
ADM
$41.6B
| $24.7M | 0.43% |
617,391
+117,980
| +24% | +$4.85M |
|
55
Progressive
PGR
$120B
| $24.7M | 0.43% |
438,705
+94,822
| +28% | +$4.91M |
|
56
Rockwell Automation
ROK
$51.3B
| $24.5M | 0.43% |
124,926
+4,136
| +3% | +$788K |
|
57
Marathon Petroleum
MPC
$91.2B
| $24.5M | 0.43% |
371,040
+39,690
| +12% | +$2.43M |
|
58
Yum! Brands
YUM
$40.6B
| $24.5M | 0.43% |
299,735
+33,170
| +12% | +$2.62M |
|
59
Hartford Financial Services
HIG
$39B
| $24M | 0.42% |
425,681
-19,080
| -4% | -$1.06M |
|
60
Lockheed Martin
LMT
$131B
| $23.9M | 0.42% |
74,354
-32,411
| -30% | -$10.2M |
|
|
AGN
61
DELISTED
Allergan plc
AGN
| $23.7M | 0.42% |
144,871
+30,730
| +27% | +$5.51M |
|
|
ARRS
62
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $23.6M | 0.41% |
918,667
-32,030
| -3% | -$901K |
|
63
Reinsurance Group of America
RGA
$15.3B
| $23.6M | 0.41% |
151,245
+9,383
| +7% | +$1.42M |
|
|
JNPR
64
DELISTED
Juniper Networks
JNPR
| $23.5M | 0.41% |
824,067
-50,810
| -6% | -$1.37M |
|
65
Bunge Global
BG
$23.7B
| $23.3M | 0.41% |
347,104
-3,560
| -1% | -$242K |
|
66
Meta Platforms (Facebook)
META
$1.54T
| $23.2M | 0.41% |
131,606
+91,320
| +227% | +$16.1M |
|
67
Cardinal Health
CAH
$52.9B
| $23.2M | 0.41% |
378,953
-5,010
| -1% | -$310K |
|
68
Capital One
COF
$123B
| $23M | 0.4% |
231,267
-36,380
| -14% | -$3.32M |
|
69
Toro Company
TTC
$8.72B
| $22.9M | 0.4% |
351,518
+13,760
| +4% | +$872K |
|
70
Baxter International
BAX
$11.2B
| $22.8M | 0.4% |
352,915
+9,090
| +3% | +$584K |
|
71
Textron
TXT
$16.2B
| $22.7M | 0.4% |
401,258
-27,710
| -6% | -$1.51M |
|
72
Fortinet
FTNT
$111B
| $22.6M | 0.4% |
2,582,215
+508,450
| +25% | +$4.14M |
|
|
ETFC
73
DELISTED
E*Trade Financial Corporation
ETFC
| $22.5M | 0.4% |
453,661
-34,730
| -7% | -$1.59M |
|
74
JPMorgan Chase
JPM
$930B
| $22.2M | 0.39% |
207,269
-450
| -0.2% | -$45.6K |
|
75
Quanta Services
PWR
$98.1B
| $21.4M | 0.38% |
546,084
+104,810
| +24% | +$3.93M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2017 Portfolio in Review
As of Q4 2017, Jacobs Levy Equity Management held 1,134 positions worth $5.69B, up 11% from $5.14B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management deployed $263M of net new capital in Q4 2017, opening 196 new positions and adding to 491 existing holdings. Its largest new stake was Yum China: 427,927 shares worth $17.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $36.5M trimmed.
- Jacobs Levy Equity Management's largest Q4 2017 buy was Yum China: 427,927 shares worth $17.1M.
- Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q4 2017, an estimated $35.7M increase.
- Jacobs Levy Equity Management's biggest Q4 2017 reduction was Johnson & Johnson, cutting an estimated $36.5M.
- Jacobs Levy Equity Management fully exited Twenty-First Century Fox, Inc. Class A in Q4 2017, selling an estimated $17.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.69B portfolio in Q4 2017.
- Jacobs Levy Equity Management opened 196 new positions and closed 159 in Q4 2017.
- Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $5.69B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2017, filed 13 Feb 2018.